# FDA Inspection 857602 - Vitalant - December 04, 2013

Source: https://www.keypedia.com/records/fda_inspections/vitalant/cd0ff999-5b34-4994-b34f-ae6d248a67d7
Source feed: FDA_Inspections

> FDA Inspection 857602 for Vitalant on December 04, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 857602
- Company Name: Vitalant
- Inspection Date: 2013-12-04
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1242893 - 2024-06-25](https://www.keypedia.com/records/fda_inspections/vitalant/242c2611-8dee-4492-8f26-2c5e2c2f3867)
- [FDA Inspection 1106648 - 2019-08-26](https://www.keypedia.com/records/fda_inspections/vitalant/8385d004-cfd7-4d75-a3cd-9014d3142688)
- [FDA Inspection 951955 - 2015-12-03](https://www.keypedia.com/records/fda_inspections/vitalant/25e66c5a-7e73-429e-8e23-699fa52d5763)
- [FDA Inspection 762537 - 2012-01-11](https://www.keypedia.com/records/fda_inspections/vitalant/90f55bd9-10da-4537-b7ce-9161878e8ec8)
- [FDA Inspection 637028 - 2010-01-06](https://www.keypedia.com/records/fda_inspections/vitalant/edce8e74-9449-464b-b5a5-c4051afd6470)

Company: https://www.keypedia.com/companies/vitalant/16485517-5285-43c4-ab48-4bf75beadec9

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d